BB

Brian R. Boettcher

NA Novartis Ag: 11 patents #279 of 5,128Top 6%
IR Irm: 1 patents #133 of 277Top 50%
🗺 Massachusetts: #11,548 of 88,656 inventorsTop 15%
Overall (All Time): #442,198 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
11944664 Fibroblast growth factor-21-Fc fusion proteins Shari Lynn Caplan, Douglas S. Daniels, Norio Hamamatsu, Stuart Licht, Stephen Craig Weldon 2024-04-02
11802152 Methods of treating FGF21-associated disorders Shari Lynn Caplan, Regis Cebe, Guochun Li, John A. Taraszka, Fangmin Xu +1 more 2023-10-31
11236159 Methods of treating FGF21-associated disorders Shari Lynn Caplan, Regis Cebe, Guochun Li, John A. Taraszka, Fangmin Xu +1 more 2022-02-01
11129874 Nucleic acids encoding FGF21-Fc fusion proteins Shari Lynn Caplan, Douglas S. Daniels, Norio Hamamatsu, Stuart Licht, Stephen Craig Weldon 2021-09-28
10669323 Methods of treating metabolic disorders with dual function fibroblast growth factor 21 proteins Shari Lynn Caplan, Susan E. Cellitti, Douglas S. Daniels, Norio Hamamatsu, Bernhard Hubert Geierstanger +3 more 2020-06-02
10076554 FGF21-FC fusion proteins for treating metabolic disorders Shari Lynn Caplan, Douglas S. Daniels, Norio Hamamatsu, Stuart Licht, Stephen Craig Weldon 2018-09-18
9458214 Dual function fibroblast growth factor 21 proteins Shari Lynn Caplan, Douglas S. Daniels, Norio Hamamatsu, Stuart Licht, Stephen Craig Weldon +3 more 2016-10-04
9266935 Methods of treating metabolic disorders with an FGF21 variant Shari Lynn Caplan, Douglas S. Daniels, Norio Hamamatsu, Stuart Licht, Stephen Craig Weldon 2016-02-23
9023791 Fibroblast growth factor 21 mutations Shari Lynn Caplan, Douglas S. Daniels, Bernhard Hubert Geierstanger, Norio Hamamatsu, Stuart Licht +2 more 2015-05-05
9006400 Fibroblast growth factor-21-Fc fusion proteins Shari Lynn Caplan, Douglas S. Daniels, Norio Hamamatsu, Stuart Licht, Stephen Craig Weldon 2015-04-14
6608038 Methods and compositions for treatment of diabetes and related conditions via gene therapy Shari Lynn Caplan, Eric D. Slosberg, Sheila Connelly, Michael Kaleko, Urvi Desai 2003-08-19